Literature DB >> 26634022

New Insights Into Tobacco-Induced Vascular Disease: Clinical Ramifications.

John P Cooke1.   

Abstract

Tobacco smoke contains more than 4,000 compounds. These include phenols, carbonyls, and nitrosamines that may be irritants and carcinogens; particulate matter such as tars; volatiles and gases such as carbon monoxide; and nicotine. Many of these compounds may contribute to the adverse health effects of tobacco. For example, recent findings have shown that the angiogenic and proliferative effects of nicotine are mediated by activation of nicotinic receptors on the vascular cells. Nicotine-induced activation of vascular cells may contribute to pathological neovascularization in cancer, age-related macular degeneration, and atherosclerosis. This review focuses on how nicotine adversely affects cardiovascular health and highlights intriguing new data about nicotine's potent angiogenic and proliferative properties.

Entities:  

Keywords:  SLURP peptides; angiogenic effect; atherosclerosis; nicotine; nicotine replacement therapy; nicotinic acetylcholine receptors; vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 26634022      PMCID: PMC4666421          DOI: 10.14797/mdcj-11-3-156

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  37 in total

1.  Extraneuronal localization of acetylcholine and its release upon nicotinic stimulation in rabbits.

Authors:  K Kawashima; H Oohata; K Fujimoto; T Suzuki
Journal:  Neurosci Lett       Date:  1989-10-09       Impact factor: 3.046

Review 2.  Smoking and age-related macular degeneration: a review of association.

Authors:  J Thornton; R Edwards; P Mitchell; R A Harrison; I Buchan; S P Kelly
Journal:  Eye (Lond)       Date:  2005-09       Impact factor: 3.775

Review 3.  Secondhand smoke and nicotine exposure: a brief review.

Authors:  Chizimuzo T C Okoli; Thomas Kelly; Ellen J Hahn
Journal:  Addict Behav       Date:  2007-01-08       Impact factor: 3.913

4.  In vitro bioactivity of combustion products from 12 tobacco constituents.

Authors:  David Préfontaine; André Morin; Catherine Jumarie; Andrew Porter
Journal:  Food Chem Toxicol       Date:  2005-12-01       Impact factor: 6.023

5.  Passive smoking: out from the haze.

Authors:  Kris Novak
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

6.  Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production.

Authors:  Christian Heiss; Nicolas Amabile; Andrew C Lee; Wendy May Real; Suzaynn F Schick; David Lao; Maelene L Wong; Sarah Jahn; Franca S Angeli; Petros Minasi; Matthew L Springer; S Katharine Hammond; Stanton A Glantz; William Grossman; John R Balmes; Yerem Yeghiazarians
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

7.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

8.  Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.

Authors:  Katsuji Kiuchi; Masato Matsuoka; Jenny C Wu; Raquel Lima e Silva; Muralitharan Kengatharan; Mary Verghese; Shinji Ueno; Katsutoshi Yokoi; Naw Htee Khu; John P Cooke; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands.

Authors:  Yasuhiro Moriwaki; Ken Yoshikawa; Hiromi Fukuda; Yoshihito X Fujii; Hidemi Misawa; Koichiro Kawashima
Journal:  Life Sci       Date:  2007-01-16       Impact factor: 5.037

10.  Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis.

Authors:  Jared M Huston; Mahendar Ochani; Mauricio Rosas-Ballina; Hong Liao; Kanta Ochani; Valentin A Pavlov; Margot Gallowitsch-Puerta; Mala Ashok; Christopher J Czura; Brian Foxwell; Kevin J Tracey; Luis Ulloa
Journal:  J Exp Med       Date:  2006-06-19       Impact factor: 14.307

View more
  1 in total

Review 1.  Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review.

Authors:  Anas A Abu Jad; Anvesh Ravanavena; Chetna Ravindra; Emmanuelar O Igweonu-Nwakile; Safina Ali; Salomi Paul; Shreyas Yakkali; Sneha Teresa Selvin; Sonu Thomas; Viktoriya Bikeyeva; Ahmed Abdullah; Aleksandra Radivojevic; Prachi Balani
Journal:  Cureus       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.